Effects of catechol estrogens and catecholamines on hypothalamic and corpus striatal tyrosine hydroxylase activity.
D000818:Animals; D002396:Catechols / Q000378:metabolism; D003342:Corpus Striatum / Q000201:enzymology*; D004298:Dopamine / Q000494:pharmacology*; D004958:Estradiol / Q000494:pharmacology; D045166:Estradiol Congeners / Q000494:pharmacology*; D004970:Estrone / Q000494:pharmacology; D006894:Hydroxyestrones / Q000494:pharmacology; D006900:Hydroxylation; D007031:Hypothalamus / Q000201:enzymology*; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology*; D011622:Pterins / Q000378:metabolism; D051381:Rats; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors / Q000378:metabolism*
D002396:Catechols; D045166:Estradiol Congeners; D006894:Hydroxyestrones; D011622:Pterins; D004970:Estrone; D004958:Estradiol; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine; D009638:Norepinephrine